| Name | Title | Contact Details |
|---|
American Diagnostic Corporation is a Hauppauge, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
HR Pharmaceuticals, Inc. is a Delaware registered corporation headquartered in York, Pennsylvania. Owner of the two (2) legacy brands of surgical lubricant: Surgilube & HR Lubricating Jelly; the standard in the medical community for over 85 years. Since the inception of HR Pharma in 2008 we have developed a reputation of quality, safety and value; these same principles date back to 1931 of producing quality products that benefit mankind. With Manufacturing Integrity and 100% compliance to ISO 9001:2008, ISO 13485:2003, cGMP requirements and the Orthodox Union, HR® creates value for our customers by continuously delivering safe and effective medical devices, pharmaceuticals & other consumer products. HR is one of central PA`s fastest growing companies. We have increased our product offering by 2000% since 2011, and are continuing this growth into 2016. We take pride in offering quality, affordable, and American made products and will continue to develop new products based on this philosophy. We emphasize a vibrant and non-bureaucratic culture which we believe has formed our meaningful and productive team.
Surgical Orthomedics, Inc. is a Pantego, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Corindus Vascular Robotics, Inc. is a global technology leader in robotic-assisted vascular interventions. The company`s CorPath® System is the first FDA-cleared medical device to bring robotic-assisted precision to radial, coronary and peripheral procedures. During the procedure, the interventional cardiologist sits at a radiation-shielded workstation to advance stents and guidewires with millimeter-by-millimeter precision. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries. With the CorPath System, Corindus Vascular Robotics brings robotic precision to radial and complex interventional procedures to help optimize clinical outcomes and minimize the costs associated with complications of improper stent placement with manual procedures. Corindus stands behind its product with its unique $1,000 hospital credit "One Stent Program."
The merged expertise of SterilMed and The Scope Exchange in the repair and reprocessing of medical devices provides the opportunity to utilize a comprehensive single-source supplier. The merged expertise combined with SterilMed's broad market presence